Ginkgo Bioworks Holdings, Inc.

BMV:DNA * Stock Report

Market Cap: Mex$9.4b

Ginkgo Bioworks Holdings Balance Sheet Health

Financial Health criteria checks 6/6

Ginkgo Bioworks Holdings has a total shareholder equity of $797.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $1.5B and $682.9M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$616.21m
EquityUS$797.94m
Total liabilitiesUS$682.94m
Total assetsUS$1.48b

Recent financial health updates

Recent updates

Financial Position Analysis

Short Term Liabilities: DNA *'s short term assets ($662.5M) exceed its short term liabilities ($114.4M).

Long Term Liabilities: DNA *'s short term assets ($662.5M) exceed its long term liabilities ($568.5M).


Debt to Equity History and Analysis

Debt Level: DNA * is debt free.

Reducing Debt: DNA * has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: DNA * has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: DNA * has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 18.4% each year.


Discover healthy companies